Trader’s Recap : Vocera Communications (NYSE:VCRA), Time Warner (NYSE:TWX), Nxstage Medical (NASDAQ:NXTM), dELiA*s, Inc. (NASDAQ:DLIA), DS Healthcare Group, Inc. (NASDAQ:DSKX)

JPMorgan Chase & Co. reiterated their neutral rating on shares of Vocera Communications (NASDAQ:VCRA) in a research report sent to investors on Friday morning. The firm currently has a $13.00 price target on the stock, down from their previous price target of $17.00. Vocera Communications, Inc. (NYSE:VCRA) belongs to Technology sector. Its net profit margin is -12.70% and weekly performance is -27.97%. On last trading day company shares ended up $8.96. Vocera Communications, Inc. (NYSE:VCRA) distance from 50-day simple moving average (SMA50) is -29.82%.

Gannett, the owner of USA Today, joins the long line of TV-focused media companies to split off its newspaper business. The spin-off plan, announced Tuesday morning, means the newspaper company will go it alone in a challenging print environment. Time Warner Inc. (NYSE:TWX), the parent of CNN, spun off its magazine unit, Time Inc., earlier this year. Time Warner Inc. (NYSE:TWX) shares decreased -12.85% in last trading session and ended the day at $74.24. TWX Gross Margin is 45.30% and its return on assets is 7.40%. Time Warner Inc. (NYSE:TWX) quarterly performance is 14.69%.

NxStage Medical (NASDAQ:NXTM) President Joseph E. Turk, Jr. sold 3,550 shares of NxStage Medical stock in a transaction dated Thursday, July 24th. The stock was sold at an average price of $13.50, for a total value of $47,925.00. Following the transaction, the president now directly owns 125,947 shares of the company’s stock, valued at approximately $1,700,285. On 06 August, Nxstage Medical, Inc. (NASDAQ:NXTM) shares decreased -0.08% and was closed at $13.20. NXTM EPS growth in last 5 year was 24.10%. Nxstage Medical, Inc. (NASDAQ:NXTM) year to date (YTD) performance is 32.00%.

dELiA*s, Inc. (NASDAQ:DLIA), an omni-channel retail company primarily marketing to teenage girls, on 18 June 2014 announced that it has received stockholder approval for an amendment to its certificate of incorporation to increase the number of authorized shares of common stock. This will allow the Company to use $24.1 million in proceeds from the sale of secured convertible notes that occurred on February 18, 2014 through the conversion of the secured convertible notes into series B convertible preferred stock. dELiA*s, Inc. (NASDAQ:DLIA) ended the last trading day at $0.49. Company weekly volatility is calculated as 10.77%and price to cash ratio as 13.89. dELiA*s, Inc. (NASDAQ:DLIA) showed a weekly performance of -20.97%.

DS Healthcare Group, Inc. (NASDAQ:DSKX), a leading developer of personal care products and specialty pharmaceuticals, announced today it has signed a distribution agreement with Drogaria Venancio, a leading Rio de Janerio-based pharmacy chain. Drogaria Venancio will sell DS Healthcare’s clinically proven personal care products including its Revita and Spectral hair re-growth and hair care products. DS Healthcare Group, Inc. (NASDAQ:DSKX) shares decreased -3.91% in last trading session and ended the day on $1.23. DSKX Gross Margin is 51.60% and its return on assets is -48.40%. DS Healthcare Group, Inc. (NASDAQ:DSKX) quarterly performance is -32.79%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone